Zentalis board member Letai frontrunner to lead NCI, STAT reports

Anthony Letai, a cancer researcher and oncologist at the Dana-Farber Cancer Institute and Harvard University and a member of the scientific advisory board at Zentalis (ZNTL), has emerged as a top candidate to serve as the next director of the National Cancer Institute, STAT News’ Matthew Herper and Angus Chen report, citing multiple sources with direct knowledge of the situation. Cancer scientists have expressed relief that Letai would lead the cancer research office, as they describe him as both kind and a highly qualified scientist, the authors note.